Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Leukemia & Lymphoma|March 1, 1996
Twelve years experience with high-dose therapy and autologous stem cell transplantation for high-risk Hodgkin's disease patients in first remission after MOPP/ABVD chemotherapyA M Carella, E Prencipe, E Pungolino, et al.
Leukemia & Lymphoma|July 27, 2016
A New Combination of Idarubicin, Etoposide and Cytarabine in Untreated Acute Non-Lymphoblastic LeukemiaA M Carella, E Gaozza, G Piatti, et al.
European Journal of Haematology|September 30, 1998
First line Fludarabine treatment of symptomatic chronic lymphoproliferative diseases: clinical results and molecular analysis of minimal residual diseaseM Clavio, M Miglino, M Spriano, et al.
Leukemia & Lymphoma|May 7, 1998
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvementG Santini, A M Congiu, S Nati, et al.
Leukemia|June 1, 1996
Mobilization/transplantation of peripheral blood progenitor cells for aggressive non-Hodgkin's lymphoma with marrow involvementG Santini, A M Congiu, S Nati, et al.
Leukemia & Lymphoma|July 28, 2016
Autologous Unpurged Bone Marrow Transplantation for Acute Non Lymphoblastic Leukemia in First RemissionA M Carella, S Nati, P Carlier, et al.
Leukemia & Lymphoma|April 30, 1999
High-dose cyclophosphamide followed by autografting can improve the outcome of relapsed or resistant non-Hodgkin's lymphomas with involved or hypoplastic bone marrowG Santini, C De Souza, A M Congiu, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 15, 2005
Upfront high-dose sequential therapy (HDS) versus VACOP-B with or without HDS in aggressive non-Hodgkin's lymphoma: long-term results by the NHLCSGA Olivieri, G Santini, C Patti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
VACOP-B versus VACOP-B plus autologous bone marrow transplantation for advanced diffuse non-Hodgkin's lymphoma: results of a prospective randomized trial by the non-Hodgkin's Lymphoma Cooperative Study GroupG Santini, L Salvagno, P Leoni, et al.
Pageof 3